Snezana Radivojev holds a PhD in Inhalation Biopharmaceutics, where she established in vitro–in silico correlations by developing novel dissolution, permeation and PBPK models. She also holds a Dipl.-Ing. in Chemical and Pharmaceutical Engineering from Graz University of Technology, and a BSc and MSc in Chemistry from the University of Novi Sad.
As Head of Pharmaceutical Development at G.ST Antivirals GmbH, she spearheaded the development of antivirals as nasal and inhaled formulations. She then joined the GTD Department of Chiesi Farmaceutici as a Senior Analytical Scientist, working on the development of pMDI products. During this time, she was involved via EFPIA as staff in the ICH Coordination Group and co-chaired IPAC-RS Dissolution working group.
She is currently a postdoctoral researcher at the University of Vienna, expanding her research towards the toxicity of inhaled microplastics.